FDA Adverse Event Injury Summary report: N

S-ROM HEAD FEMORAL COCR 32+3

MDR report key: 3122388 · Received May 21, 2013

Report

Report Number
1818910-2013-17437
Event Type
Injury
Date Received
May 21, 2013
Date of Event
April 17, 2013
Report Date
April 17, 2013
Manufacturer
1818910 DEPUY ORTHOPAEDICS, INC.
Product Code
JDG
PMA / PMN Number
PK920317
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATIONS SINCE THEIR RELEASE FOR DISTRIBUTION. REVIEW OF PROVIDED MEDICAL RECORDS DOES NOT IDENTIFY ANY INFORMATION THAT WOULD AID IN CONCLUDING THE REPORTED INFECTION WAS DEVICE RELATED. ADDITIONALLY, RESEARCH USING THE AS400 SYSTEM INDICATES THAT SEVERAL PIECES FROM THE REPORTED LOTS HAVE BEEN DELIVERED, AND, AS NO ADDITIONAL REPORTS HAVE BEEN RECEIVED, CAN BE REASONABLY ASSUMED IMPLANTED WITHOUT ISSUE. THE INVESTIGATION COULD NOT DRAW ANY CONCLUSIONS REGARDING THE REPORTED EVENT. BASED ON THE INABILITY TO DETERMINE A ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED.

Additional Manufacturer Narrative · 1

(B)(4). DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE REOPENED AS NECESSARY.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS STAPH INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
224335 S-ROM HEAD FEMORAL COCR 32+3 FEMORAL HEAD JDG 1818910 DEPUY ORTHOPAEDICS, INC. 3397255

Patients

Seq Age Sex Outcome Treatment
1 76 YR Required Intervention